Back to Search
PRADEEP RAJAGOPALAN, MD
MD
Diagnostic Radiology Physician
NPI: 1750354262IndividualAccepts Medicare
Specialties, Licenses & Credentials
Vascular & Interventional Radiology Physician
Radiology — Vascular & Interventional Radiology
Code: 2085R0204X
0101226799(VA)
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
0101226799(VA)
Education
DUKE UNIVERSITY SCHOOL OF MEDICINE
Class of 1995
Research & Publications (20)
Polyelectrolyte nano-scaffolds for the design of layered cellular architectures.
PMID 16846351·Tissue Eng·2006
7-preclinical
Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics.
PMID 12359872·Proc Natl Acad Sci U S A·2002
8-other
Coupling interactions of distal residues enhance dihydrofolate reductase catalysis: mutational effects on hydride transfer rates.
PMID 12379104·Biochemistry·2002
8-other
UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib.
PMID 19672597·Cancer Chemother Pharmacol·2009
5-case
HCV NS5B polymerase inhibitors 2: Synthesis and in vitro activity of (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyridine and azolo[1,5-a]pyrimidine derivatives.
PMID 19500983·Bioorg Med Chem Lett·2009
7-preclinical
Nano- and sub-micron porous polyelectrolyte multilayer assemblies: biomimetic surfaces for human corneal epithelial cells.
PMID 19446874·Biomaterials·2009
8-other
Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor beta, and c-Kit, in patients with advanced or metastatic solid tumors.
PMID 19636022·J Clin Oncol·2009
3-trial
Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy.
PMID 18279104·J Interferon Cytokine Res·2008
3-trial
Cellular response to nanoscale elastin-like polypeptide polyelectrolyte multilayers.
PMID 18178532·Acta Biomater·2008
7-preclinical
Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours.
PMID 19002179·Br J Cancer·2008
3-trial
Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitor.
PMID 18519779·Clin Cancer Res·2008
3-trial
Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227).
PMID 18824605·Antimicrob Agents Chemother·2008
7-preclinical
The use of elastin-like polypeptide-polyelectrolyte complexes to control hepatocyte morphology and function in vitro.
PMID 18006054·Biomaterials·2008
7-preclinical
A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation.
PMID 17564637·Am J Transplant·2007
3-trial
Hallmarks of mycolic acid biosynthesis: a comparative genomics study.
PMID 17600834·Proteins·2007
4-observational
Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation.
PMID 17198261·Transplantation·2006
4-observational
Parenchymal transection of the kidney inflicted by endocatch bag entrapment during a laparoscopic donor nephrectomy.
PMID 16433781·Am J Transplant·2006
5-case
Identification of borinic esters as inhibitors of bacterial cell growth and bacterial methyltransferases, CcrM and MenH.
PMID 16279806·J Med Chem·2005
8-other
Does bioequivalence between modified cyclosporine formulations translate into equal outcomes?
PMID 16371936·Transplantation·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 500 MARTHA JEFFERSON DR, CHARLOTTESVILLE RADIOLOGY
CHARLOTTESVILLE, VA 22911 - Phone
- (434) 244-4580
Quick Facts
- NPI
- 1750354262
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile